Hi BASIAC, Thanks for sharing. PNV are not on the list to watch, however they are mentioned within the article, see below:
Page 4. Australian biotechnology developments include the Cochlear implant now being sold by Cochlear globally and Resmed’s (RMD) CPAP device helping many people with sleep apnoea.Other home-grown technologies occupying a spot on the world stage include a disinfection system for ultrasound probes by Nanosonics (NAN) and Polynovo’s (PNV) synthetic absorbable polymers.
Page 8.
Hester says companies that raised money in 2020-2021 are sitting pretty, pointing to Avita Medical (AVH) and Polynovo (PNV) as examples.“Avita is still burning cash at quite a rate, but it’s held up really well because it’s got plenty of cash in the bank, and also a bit of revenue,” he said.“Polynovo doesn’t have a lot of cash in the bank but, similarly, it does have strong revenue growth. “In contrast, a stock like Aroa Biosurgery (ARX) which has ~$50 million in the bank, is not yet A re-capitalisation cycle is imminent, says Bell Potter healthcare analyst John Hester, and health and biotech stocks with cash in the bank will sit ahead of the packHow to catch the biotech bounce backEmma Davies cashfow positive, but has held up really well.
In my opinion, Polynovo is too established to be included in this list.
- Forums
- ASX - By Stock
- PNV
- PNV - Banter and General Comments
PNV - Banter and General Comments, page-10387
-
- There are more pages in this discussion • 2,369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.38 |
Change
0.060(2.59%) |
Mkt cap ! $1.643B |
Open | High | Low | Value | Volume |
$2.35 | $2.39 | $2.33 | $2.357M | 995.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 232 | $2.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 3934 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 232 | 2.370 |
3 | 11692 | 2.360 |
5 | 20879 | 2.350 |
1 | 2161 | 2.340 |
2 | 6978 | 2.330 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 3934 | 1 |
2.390 | 185006 | 6 |
2.400 | 76851 | 7 |
2.410 | 16999 | 4 |
2.420 | 31146 | 3 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online